News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BrainStorm Cell Therapeutics Inc. Receives Grant from Israel’s Office of the Chief Scientist



9/26/2011 10:36:17 AM

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), an innovative developer of adult stem cell therapeutics targeting Central Nervous System (CNS) diseases, today announced that it received notice from Israel’s Office of the Chief Scientist (OCS) of its commitment to grant the Company approximately $1.1 million (NIS 3.8 million) in accordance with OCS requirements.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES